Search Results 61-70 of 17189 for ulcerative colitis
The global primary objectives of this study are, in pediatric participants with moderately to severely active ulcerative colitis (UC):. To evaluate the efficacy ...
Proctitis caused by inflammatory bowel disease. Treatment of proctitis related to Crohn's disease or ulcerative colitis is aimed at reducing the inflammation in ...
For treatment of ulcerative colitis: For oral dosage form (enteric-coated tablets):. Adults—At first, 500 to 1000 milligrams (mg) every 6 to 8 ...
... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
While small bowel CE has been fairly well studied in CD , colon capsule endoscopy (CCE) for ulcerative colitis (UC) has not been as well studied. Therefore ...
Consecutive patients with ulcerative colitis who attend the IBD Clinic in the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester and ...
If you take a look at all forms of inflammatory bowel disease, both Crohn's disease and ulcerative colitis, the incidence has actually been increasing. Narrator ...
... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.
The purpose of this study is to determine the long-term safety of vedolizumab intravenous (IV) treatment in pediatric participants with Ulcerative Colitis (UC) ...
Mesalamineenema is used to treat active mild to moderate ulcerative colitis, proctitis or proctosigmoiditis (inflammation of the rectum and bowel). It works ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.